Case studies: octenidine in the management of diabetic foot ulcers

Andrew Sharpe, Ana Formiga, Jose Neves, Eugenia Serafino, Claudia Silva, Marino Machado

Research output: Contribution to journalArticle


Diabetic foot ulcers (DFUs) are common and constitute a considerable burden
for both patients and healthcare providers. Reducing the length of time to
healing reduces the risk of infection and further morbidity. Biofilms delay
healing, therefore, they should be treated with a biofilm-based wound care
regimen consisting of debridement, topical agents (antimicrobials and antiseptics)
and, if appropriate, systemic antibiotics (Cutting and Westgate, 2012). This
case series focuses on the use of octenilin®, which contains a broad-spectrum
antimicrobial, in the treatment of DFUs to address bioburden, prevent infection
and progress healing.
Original languageEnglish
Pages (from-to)192-197
Number of pages6
JournalThe Diabetic Foot Journal
Issue number3
Publication statusPublished - 13 Sep 2018


Cite this

Sharpe, A., Formiga, A., Neves, J., Serafino, E., Silva, C., & Machado, M. (2018). Case studies: octenidine in the management of diabetic foot ulcers. The Diabetic Foot Journal, 21(3), 192-197.